In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk
Alex Nachman, Zain Chagla
Annals of Internal Medicine · 2025-02
Abstract
CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Infectious Disease: [Formula: see text] Pulmonology: [Formula: see text].
MeSH terms
- Bedaquiline
- Medicine
- Rifampicin
- Regimen
- Internal medicine
- Tuberculosis
- Isoniazid